Hong Fang Song
Director/Miembro de la Junta en CG ONCOLOGY, INC. .
Fortuna: 20 M $ al 31/05/2024
Perfil
Hong Fang Song is an Independent Director at CG Oncology, Inc. and a Director at Enable Injections, Inc. She previously worked as a Managing Director at Cowen, Inc. She holds a graduate degree from Claremont Graduate University and an undergraduate degree from Fudan University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.92% | 25/03/2024 | 613 928 ( 0.92% ) | 20 M $ | 31/05/2024 |
Cargos activos de Hong Fang Song
| Empresas | Cargo | Inicio |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Miembro de la Junta | 01/11/2015 |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Hong Fang Song.
| Empresas | Cargo | Fin |
|---|---|---|
| COWEN INC. | Corporate Officer/Principal | - |
Formación de Hong Fang Song.
| Fudan University | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm’s private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Hong Fang Song
